Industry reports
Editor highlights

Publication dates

All regions

data types

Pharmacokinetics Market and Forecasts, April 2014

You might be interested in: clinical trial, biosimilar, drug, more »

1-10 of about 300 reports for Pharmacokinetics

Drug Discovery and Development : Innovation and Technology Trends

  • Industry report
  • March 2013
  • 42 pages

... pharmacokinetics Target occupancy Target activation Pharmacological response phase ii Pathophysiological response circlecopyrt inhecon jochen theis 12th april ...

Drug and Medication Sector Brief

  • Industry report
  • January 2012
  • 5 pages

... Demonstrated against many diseases of domestic animals [8-14]. However, to date, studies on the efficacy of florfenicol using pharmacokinetic/ pharmacodynamic (pk/ pd) approaches have not been carried out ...

Drug and Medication Market Brief

  • Industry report
  • March 2012
  • 7 pages

... For bioequivalence and pharmacokinetic studies. Furthermore, these methods require a number of procedures for sample preparation such as liquid- liquid and solid phase extraction which complicate them. Some other ...

Infectious Disease Industry Overview (infectious disease, blood disease)

  • Industry report
  • May 2013
  • 21 pages

... And streamlining Dose optimization Patient characteristics Renal function, age, weight Site of infection Meningitis, neutropenic fever, pneumonia pharmacokinetics Monitoring levels Iv to po ...

Drug and Medication Market in Hungary

  • Industry report
  • July 2012
  • 16 pages

... The acceptance range as defined below for ln-transformed pharmacokinetic parameters cmax and auc0-t for eplerenone. The predefined acceptance criterion for the confidence interval of the cmax and auc0-t ratios ...

The Austrian Drug and Medication Industry Brief

  • Industry report
  • January 2012
  • 5 pages

... At which 90% of frequently isolated bacteria are inhibited were close to or higher than 100 h. Therefore, based on pharmacokinetic and pharmacodynamic calculations, we conclude that gemifloxacin might ...

Drug and Medication Market Analysis in The United States

  • Industry report
  • September 2012
  • 86 pages

... Introduction to clearance clearance is a Primary Parameter in the pharmacokinetic analysis of drug distribution and elimination. Understanding the concept of clearance is essential for drug ...

Tobacco Product Market in Sweden and The United Kingdom

  • Industry report
  • April 2012
  • 7 pages

... This differing pharmacokinetic profile is a contributing factor to nrt products Limited success as aids for quitting smoking (britton, 2008). There is little published information on nicotine absorption from ...

Diagnostics Sector Brief

  • Industry report
  • January 2012
  • 8 pages

... Performed in asian (japanese) healthy subjects did not reveal a different pharmacokinetic profile compared to caucasian healthy subjects. Similarly, no plasma clearance differences were observed between ...

Pharmaceutical Market in Ireland

  • Industry report
  • January 2012
  • 6 pages

... Of the dose given as nicorandil and 6.8 To 17.3% As its metabolite n-(2-hydroxyethyl) nicotinamide. pharmacokinetics in special populations hepatic impairment no formal study of the effect of hepatic impairment ...

» Purchase Premium Reports (From $ 125 - $ 4 595)

12 reports for Pharmacokinetics
Worldwide Clinical Trials, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Worldwide Clinical Trials, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

Summary Worldwide Clinical Trials, Inc. (WCT) is a contract research organization (CRO). It undertakes clinical research in the areas Central Nervous System, Cardiovascular, Oncology, respiratory and chronic ...

» Read our Company Profiles

1 Companies for Pharmacokinetics

Roche Holding AG


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.